Literature DB >> 29356618

Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift.

Meghan O Altman1, Davide Angeletti1, Jonathan W Yewdell1.   

Abstract

Influenza A virus (IAV) imposes a significant socioeconomic burden on humanity. Vaccination is effective in only 60% of individuals, even under optimal circumstances. The difficulty stems from the remarkable ability of IAV to evade existing immunity. IAV's error prone polymerase enables the rapid antigenic evolution of the two virion surface glycoproteins, neuraminidase and hemagglutinin (HA). Since the most potent antibodies (Abs) at neutralizing viral infectivity are directed the head of the HA, amino acid substitutions in this region enable IAV to evade Ab-based immunity. Here, we review recent progress in understanding how immunodominance, the tendency of the immune system to respond to foreign immunogens in a hierarchical manner, shapes IAV evolution.

Entities:  

Keywords:  antibody immunodominance; antigenic drift; influenza A virus; vaccines

Mesh:

Substances:

Year:  2018        PMID: 29356618      PMCID: PMC5863095          DOI: 10.1089/vim.2017.0129

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  65 in total

1.  Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components.

Authors:  Krystyna Mozdzanowska; Jingqi Feng; Mark Eid; Darya Zharikova; Walter Gerhard
Journal:  Virology       Date:  2006-06-14       Impact factor: 3.616

2.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

3.  Topological mapping antigenic sites on the influenza A/PR/8/34 virus hemagglutinin using monoclonal antibodies.

Authors:  M D Lubeck; W Gerhard
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

4.  IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.

Authors:  Chang-Han Lee; Gabrielle Romain; Wupeng Yan; Makiko Watanabe; Wissam Charab; Biliana Todorova; Jiwon Lee; Kendra Triplett; Moses Donkor; Oana I Lungu; Anja Lux; Nicholas Marshall; Margaret A Lindorfer; Odile Richard-Le Goff; Bianca Balbino; Tae Hyun Kang; Hidetaka Tanno; George Delidakis; Corrine Alford; Ronald P Taylor; Falk Nimmerjahn; Navin Varadarajan; Pierre Bruhns; Yan Jessie Zhang; George Georgiou
Journal:  Nat Immunol       Date:  2017-06-12       Impact factor: 25.606

5.  CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection.

Authors:  Byung O Lee; Javier Rangel-Moreno; Juan E Moyron-Quiroz; Louise Hartson; Melissa Makris; Frank Sprague; Frances E Lund; Troy D Randall
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

6.  Complex Antigens Drive Permissive Clonal Selection in Germinal Centers.

Authors:  Masayuki Kuraoka; Aaron G Schmidt; Takuya Nojima; Feng Feng; Akiko Watanabe; Daisuke Kitamura; Stephen C Harrison; Thomas B Kepler; Garnett Kelsoe
Journal:  Immunity       Date:  2016-03-03       Impact factor: 31.745

7.  Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance.

Authors:  Scott E Hensley; Suman R Das; James S Gibbs; Adam L Bailey; Loren M Schmidt; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

8.  Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Authors:  Martin T Ferris; David L Aylor; Daniel Bottomly; Alan C Whitmore; Lauri D Aicher; Timothy A Bell; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Lisa E Gralinski; Bart L Haagmans; Leonard McMillan; Darla R Miller; Elizabeth Rosenzweig; William Valdar; Jeremy Wang; Gary A Churchill; David W Threadgill; Shannon K McWeeney; Michael G Katze; Fernando Pardo-Manuel de Villena; Ralph S Baric; Mark T Heise
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

9.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.

Authors:  L M Staudt; W Gerhard
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Coordinated Evolution of Influenza A Surface Proteins.

Authors:  Alexey D Neverov; Sergey Kryazhimskiy; Joshua B Plotkin; Georgii A Bazykin
Journal:  PLoS Genet       Date:  2015-08-06       Impact factor: 5.917

View more
  44 in total

Review 1.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

2.  Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.

Authors:  Jae-Keun Park; Yongli Xiao; Mitchell D Ramuta; Luz Angela Rosas; Sharon Fong; Alexis M Matthews; Ashley D Freeman; Monica A Gouzoulis; Natalia A Batchenkova; Xingdong Yang; Kelsey Scherler; Li Qi; Susan Reed; Rani Athota; Lindsay Czajkowski; Alison Han; David M Morens; Kathie-Anne Walters; Matthew J Memoli; John C Kash; Jeffery K Taubenberger
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

Review 3.  The Multifaceted B Cell Response to Influenza Virus.

Authors:  Jonathan H Lam; Nicole Baumgarth
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

4.  Influenza Viruses in Mice: Deep Sequencing Analysis of Serial Passage and Effects of Sialic Acid Structural Variation.

Authors:  Brian R Wasik; Ian E H Voorhees; Karen N Barnard; Brynn K Alford-Lawrence; Wendy S Weichert; Grace Hood; Aitor Nogales; Luis Martínez-Sobrido; Edward C Holmes; Colin R Parrish
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

5.  Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.

Authors:  Jefferson J S Santos; Eugenio J Abente; Adebimpe O Obadan; Andrew J Thompson; Lucas Ferreri; Ginger Geiger; Ana S Gonzalez-Reiche; Nicola S Lewis; David F Burke; Daniela S Rajão; James C Paulson; Amy L Vincent; Daniel R Perez
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.

Authors:  Felix Broecker; Sean T H Liu; Weina Sun; Florian Krammer; Viviana Simon; Peter Palese
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

7.  The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus.

Authors:  Benjamin O Fulton; Weina Sun; Nicholas S Heaton; Peter Palese
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

8.  Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.

Authors:  Sean T H Liu; Mohammad Amin Behzadi; Weina Sun; Alec W Freyn; Wen-Chun Liu; Felix Broecker; Randy A Albrecht; Nicole M Bouvier; Viviana Simon; Raffael Nachbagauer; Florian Krammer; Peter Palese
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

9.  Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.

Authors:  Weina Sun; Davina S Kang; Allen Zheng; Sean T H Liu; Felix Broecker; Viviana Simon; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.

Authors:  Assaf Amitai; Maya Sangesland; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Daniel Lingwood; Arup K Chakraborty
Journal:  Cell Syst       Date:  2020-10-07       Impact factor: 10.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.